Menu
GWAS Study

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

Barnes DR, Tyrer JP, Dennis J et al.

41266372 PubMed ID
GWAS Study Type
120248 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BD
Barnes DR
TJ
Tyrer JP
DJ
Dennis J
LG
Leslie G
BM
Bolla MK
LM
Lush M
AA
Aeilts AM
AK
Aittomäki K
AN
Andrieu N
AI
Andrulis IL
AH
Anton-Culver H
AA
Arason A
AB
Arun BK
BJ
Balmaña J
BE
Bandera EV
BR
Barkardottir RB
BL
Berger LPV
BD
Berrington de Gonzalez A
BP
Berthet P
BK
Białkowska K
BL
Bjørge L
BA
Blanco AM
BM
Blok MJ
BK
Bobolis KA
BN
Bogdanova NV
BJ
Brenton JD
BH
Butz H
BS
Buys SS
CM
Caligo MA
CI
Campbell I
CC
Castillo C
CK
Claes KBM
CS
Colonna SV
CL
Cook LS
DM
Daly MB
DA
Dansonka-Mieszkowska A
DL
de la Hoya M
DA
deFazio A
DA
DePersia A
DY
Ding YC
DJ
Doherty JA
DS
Domchek SM
DT
Dörk T
EZ
Einbeigi Z
EC
Engel C
ED
Evans DG
FL
Foretova L
FR
Fortner RT
FF
Fostira F
FM
Foti MC
FE
Friedman E
FM
Frone MN
GP
Ganz PA
GA
Gentry-Maharaj A
GG
Glendon G
GA
Godwin AK
GA
González-Neira A
GM
Greene MH
GJ
Gronwald J
GA
Guerrieri-Gonzaga A
HU
Hamann U
HT
Hansen TVO
HH
Harris HR
HJ
Hauke J
HF
Heitz F
HF
Hogervorst FBL
HM
Hooning MJ
HJ
Hopper JL
HC
Huff CD
HD
Huntsman DG
IE
Imyanitov EN
IL
Izatt L
JA
Jakubowska A
JP
James PA
JR
Janavicius R
JE
John EM
KS
Kar S
KB
Karlan BY
KC
Kennedy CJ
KL
Kiemeney LALM
KI
Konstantopoulou I
KJ
Kupryjanczyk J
LY
Laitman Y
LO
Lavie O
LK
Lawrenson K
LJ
Lester J
LF
Lesueur F
LC
Lopez-Pleguezuelos C
MP
Mai PL
MS
Manoukian S
MT
May T
MI
McNeish IA
MU
Menon U
MR
Milne RL
MF
Modugno F
MJ
Mongiovi JM
MM
Montagna M
MK
Moysich KB
NS
Neuhausen SL
NF
Nielsen FC
NC
Noguès C
OE
Oláh E
OO
Olopade OI
OA
Osorio A
PL
Papi L
PH
Pathak H
PC
Pearce CL
PI
Pedersen IS
PA
Peixoto A
PT
Pejovic T
PP
Peng PC
PB
Peshkin BN
PP
Peterlongo P
PC
Powell CB
PD
Prokofyeva D
PM
Pujana MA
RP
Radice P
RM
Rashid MU
RG
Rennert G
RG
Richenberg G
SD
Sandler DP
SN
Sasamoto N
SV
Setiawan VW
SP
Sharma P
SW
Sieh W
SC
Singer CF
SK
Snape K
SA
Sokolenko AP
SP
Soucy P
SM
Southey MC
SD
Stoppa-Lyonnet D
SR
Sutphen R
SC
Sutter C
TY
Tan YY
TM
Teixeira MR
TK
Terry KL
TL
Thomsen LCV
TM
Tischkowitz M
TA
Toland AE
VG
Van Gorp T
VA
Vega A
VE
Velez Edwards DR
WP
Webb PM
WJ
Weitzel JN
WN
Wentzensen N
WA
Whittemore AS
WS
Winham SJ
WA
Wu AH
YS
Yadav S
YY
Yu Y
ZA
Ziogas A
BA
Berchuck A
CF
Couch FJ
GE
Goode EL
GM
Goodman MT
MA
Monteiro AN
OK
Offit K
RS
Ramus SJ
RH
Risch HA
SJ
Schildkraut JM
TM
Thomassen M
SJ
Simard J
ED
Easton DF
JM
Jones MR
CG
Chenevix-Trench G
GS
Gayther SA
AA
Antoniou AC
PP
Pharoah PDP
Chapter II

Abstract

Summary of the research findings

Nineteen genomic regions have been associated with high-grade serous ovarian cancer (HGSOC). We meta-analyzed >22 million variants for 398,238 women from the Ovarian Cancer Association Consortium (OCAC), UK Biobank (UKBB) and Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA) to identify novel HGSOC susceptibility loci. Eight novel variants were associated with HGSOC risk. An interesting discovery biologically was TP53 3'-UTR SNP rs78378222-T's association with HGSOC (per-T-allele relative risk (RR) = 1.44, 95% CI:1.28-1.62, P = 1.76 × 10-9). Polygenic scores (PGS) were developed using OCAC and CIMBA data and trained on FinnGen data. The optimal PGS included 64,518 variants and was associated with an odds ratio of 1.46 (95% CI:1.37-1.54) per standard deviation when validated in the UKBB. This study represents the largest HGSOC GWAS to date - demonstrating that improvements in imputation reference panels and increased sample sizes help to identify HGSOC associated variants that previously went undetected, ultimately improving PGS which can improve personalized HGSOC risk prediction.

15,361 European ancestry female cases, 104,887 European ancestry female controls

Chapter III

Study Statistics

Key metrics and study information

120248
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Russian Federation, Belarus, Spain, Greece, Canada, Netherlands, Sweden, U.S., Belgium, Norway, Finland, Denmark, Poland, U.K., Australia, Germany, Portugal, Austria, Latvia, Pakistan, France, Lithuania, Colombia, Hungary, Republic of Ireland, Czech Republic, Italy, South Africa, Israel, Iceland
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.